American Association of Individual Investors

Which Is a Better Investment, Twist Bioscience Corporation or Zymeworks Inc. Stock?

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
News-Medical.Net on MSN

Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
CBS 42

ABL Diagnostics Announces Partnership with seqWell to Advance NGS Library Preparation for Infectious Disease

With the support of seqWell’s technology, ABL is bringing to market a high-value, next-generation library preparation solution that enhances the DeepChek ® workflow and accelerates access to rapid, ...
TMCnet

Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform

BOSTON, Nov. 14, 2025 /PRNewswire/ -- Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned provider of life science reagents, today announced a ...
The McDuffie Progress

Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform

Please purchase a subscription to read our premium content. If you have a subscription, please log in or sign up for an account on our website to continue.
MarketWatch

Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.

SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next ...